U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07413133) titled 'A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers' on Feb. 10.
Brief Summary: The purpose of this study is to assess the pharmacokinetics (PK), bioavailability, immunogenicity, safety, and tolerability of ABBV-8736 following subcutaneous (SC) administration relative to intravenous (IV) administration.
Study Start Date: Feb. 09
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: ABBV-8736
Intravenous Injection
DRUG: ABBV-8736
Subcutaneous Injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AbbVie
Published b...